SCHEMBL7196695

SCHEMBL7196695

COc1ccc(OC)c(C=CC(=O)c2c(OC)c(OC)cc(OC)c2OC)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.70
PDE4A P27815 1/20 0.67
PDE4B Q07343 1/20 0.67
PDE4C Q08493 1/20 0.67
PDE4D Q08499 1/20 0.67
JUN P05412 1/20 0.67
NFKB1 P19838 1/20 0.67
MAPT P10636 3/20 0.62
KDM4E B2RXH2 1/20 0.62
LMNA P02545 1/20 0.62
ATM Q13315 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
TNFRSF1A P19438 2/20 0.55
APP P05067 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
POLB P06746 1/20 0.55
KRAS P01116 1/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196690 1.00 ABCG2 (0.70) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7193430 0.92 ABCG2 (0.70) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7193424 0.92 ABCG2 (0.70) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7195677 0.86 ABCG2 (0.56) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7195693 0.86 ABCG2 (0.56) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7187243 0.84 PDE4A (0.76) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7187238 0.84 PDE4A (0.76) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL25952882 0.83 ABCG2 (0.58) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7194762 0.83 TNFRSF1A (0.52) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7194770 0.83 TNFRSF1A (0.52) ABCG2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed
EP-0996432-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUMINSTITUT (DK) 2000-05-03 EP claimed
WO-1999000114-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUM INSTITUT (DK) 1999-01-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 ABCG2 1177/4885PDE4A 3419/4885PDE4B 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.